Skip to content

Efficacy of novel endoscopic laparoscopy combined with gastric cancer in the treatment of gastric cancer

Efficacy of novel endoscopic laparoscopy combined with gastric cancer in the treatment of gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099070
Enrollment
Unknown
Registered
2025-03-18
Start date
2024-04-10
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Sponsors

The First Affiliated Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-85 years old, gender is not limited; 2.Patients with T1 and T2 gastric cancer who are clinically diagnosed as indications for ultraendoscopic treatment by preoperative gastroscopy, magnifying gastroscopy, ultrasound gastroscopy, CT and other examinations; 3. Gastric cancer patients undergoing endoscopic or laparoscopic treatment in our hospital.

Exclusion criteria

Exclusion criteria: 1. Patients with metastatic lesions from distant organs such as chest CT and abdominal CT before surgery, or patients with other malignant tumors; 2. Patients with ultra-T2 gastric cancer pathologically evaluated after laparoscopic surgery.

Design outcomes

Primary

MeasureTime frame
Five-year survival rate;

Secondary

MeasureTime frame
Duration of surgery;Number of perigastric lymph node dissections and metastases;Short-term complications;Intraoperative blood loss;Total length of hospital stay;Long-term complication;Anal exhaust time;Fasting time;Length of hospital stay after surgery;

Countries

China

Contacts

Public ContactGuiyong Peng

The First Affiliated Hospital of the Army Medical University

pgy63@163.com+86 158 2380 7075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026